Thank you, Mr. Chair.
Mr. Lucas, Health Canada takes pains to point out that maintaining the interim order continues to make Canada an attractive place to conduct clinical trials. You therefore recognize the importance of clinical trials in ensuring that patients have access to treatment options.
What is true for COVID‑19 is also true for life-threatening or rare diseases, diseases like cancer or immune system dysfunctions. Do you agree with me?